Oncological Surgery During the COVID-19 Pandemic: The Need for Deep and Lasting Measures

Amine Souadka; Amine Benkabbou; Mohammed Anass Majbar; Hajar Essangri; Laila Amrani; Raouf Mohsine; Abdelilah Ghannam; Brahim El Ahmadi; Zakaria Belkhadir

doi:10.1634/theoncologist.2020-0360

Oncological Surgery During the COVID-19 Pandemic: The Need for Deep and Lasting Measures

Oncologist. 2020 Sep;25(9):e1424-e1425. doi: 10.1634/theoncologist.2020-0360. Epub 2020 Jun 23.

Authors

Amine Souadka¹, Amine Benkabbou¹, Mohammed Anass Majbar¹, Hajar Essangri¹, Laila Amrani¹, Raouf Mohsine¹, Abdelilah Ghannam², Brahim El Ahmadi², Zakaria Belkhadir²

Affiliations

¹ Department of Surgical Oncology, National Institute of Oncology, University Mohammed V, Rabat, Morocco.
² Department of Intensive Care, National Institute of Oncology, University Mohammed V, Rabat, Morocco.

Abstract

This letter to the editor describes a patient with metastatic prostate cancer harboring a biallelic somatic CDK12 mutation and their response to a platinum‐based combination therapy.

Publication types

Letter

MeSH terms

COVID-19 / epidemiology*
COVID-19 / prevention & control
Humans
Infection Control / standards
Medical Oncology / standards*
Neoplasms / surgery*
Practice Guidelines as Topic
Resource Allocation / standards
SARS-CoV-2